[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 501", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 484 0899", "website": "https://dayonebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.", "fullTimeEmployees": 174, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy  Bender M.B.A., Ph.D.", "age": 53, "title": "CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 1048400, "exercisedValue": 0, "unexercisedValue": 64677}, {"maxAge": 1, "name": "Mr. Charles N. York II, M.B.A.", "age": 47, "title": "COO, CFO & Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 760000, "exercisedValue": 0, "unexercisedValue": 24599}, {"maxAge": 1, "name": "Mr. Adam  Dubow J.D.", "age": 57, "title": "General Counsel and Chief Compliance Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 608200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Stubenrauch Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaa  Roberson", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Davy  Chiodin Ph.D., Pharm.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Merendino M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elly  Barry M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.23, "open": 12.38, "dayLow": 12.19, "dayHigh": 12.46, "regularMarketPreviousClose": 12.23, "regularMarketOpen": 12.38, "regularMarketDayLow": 12.19, "regularMarketDayHigh": 12.46, "payoutRatio": 0.0, "beta": -1.464, "forwardPE": -11.098214, "volume": 737322, "regularMarketVolume": 725499, "averageVolume": 969011, "averageVolume10days": 708880, "averageDailyVolume10Day": 708880, "bid": 12.41, "ask": 12.45, "bidSize": 2, "askSize": 3, "marketCap": 1253515776, "fiftyTwoWeekLow": 11.13, "fiftyTwoWeekHigh": 18.07, "priceToSalesTrailing12Months": 12.295035, "fiftyDayAverage": 12.458, "twoHundredDayAverage": 13.82295, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 677582144, "profitMargins": -0.82678, "floatShares": 71532293, "sharesOutstanding": 100846000, "sharesShort": 17291281, "sharesShortPriorMonth": 18548290, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.1715, "heldPercentInsiders": 0.16983, "heldPercentInstitutions": 0.94984, "shortRatio": 15.5, "shortPercentOfFloat": 0.20709999, "impliedSharesOutstanding": 100846000, "bookValue": 5.51, "priceToBook": 2.2558982, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -84293000, "trailingEps": -0.97, "forwardEps": -1.12, "enterpriseToRevenue": 6.646, "enterpriseToEbitda": -3.297, "52WeekChange": -0.19433463, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 12.43, "targetHighPrice": 43.0, "targetLowPrice": 25.0, "targetMeanPrice": 35.44444, "targetMedianPrice": 34.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 558382976, "totalCashPerShare": 5.537, "ebitda": -205504000, "totalDebt": 2615000, "quickRatio": 14.268, "currentRatio": 14.618, "totalRevenue": 101953000, "debtToEquity": 0.471, "revenuePerShare": 1.144, "returnOnAssets": -0.25426, "returnOnEquity": -0.17838, "grossProfits": 99656000, "freeCashflow": -151710368, "operatingCashflow": -89477000, "grossMargins": 0.97747004, "ebitdaMargins": -2.01567, "operatingMargins": 0.31608, "financialCurrency": "USD", "symbol": "DAWN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1740172442, "regularMarketTime": 1740171602, "corporateActions": [], "exchange": "NMS", "messageBoardId": "finmb_704589075", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.6353292, "regularMarketPrice": 12.43, "marketState": "POST", "shortName": "Day One Biopharmaceuticals, Inc", "longName": "Day One Biopharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622122200000, "postMarketChangePercent": -1.3676594, "postMarketPrice": 12.26, "postMarketChange": -0.17000008, "regularMarketChange": 0.20000076, "regularMarketDayRange": "12.19 - 12.46", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 969011, "cryptoTradeable": false, "fiftyTwoWeekLowChange": 1.3000002, "fiftyTwoWeekLowChangePercent": 0.116801456, "fiftyTwoWeekRange": "11.13 - 18.07", "fiftyTwoWeekHighChange": -5.6399994, "fiftyTwoWeekHighChangePercent": -0.3121195, "fiftyTwoWeekChangePercent": -19.433462, "epsTrailingTwelveMonths": -0.97, "epsForward": -1.12, "epsCurrentYear": -0.67125, "priceEpsCurrentYear": -18.517693, "fiftyDayAverageChange": -0.027999878, "fiftyDayAverageChangePercent": -0.002247542, "twoHundredDayAverageChange": -1.39295, "twoHundredDayAverageChangePercent": -0.10077082, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-27", "averageAnalystRating": "1.7 - Buy", "displayName": "Day One Biopharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]